BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
No open-market purchases or sales by BIO-TECHNE Corp insiders were filed in the last 90 days; 601 institutions reported holding it in 13F filings for Q2 2026, worth $12.3B in total; 3 superinvestors hold it, including Maverick Capital and Weitz Investment Management.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:33 PM ET
Revenue flow, FY2026
Where the revenue went in FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Aug 12, 2026 | Aug 6, 2025 | Aug 7, 2024 | Aug 8, 2023 | Aug 4, 2022 |
| Revenue | $1.22B | $1.22B | $1.16B | $1.14B | $1.11B |
| Cost of revenue | $416.0M | $429.4M | $389.3M | $366.9M | $349.1M |
| Gross profit | $799.1M | $790.3M | $769.7M | $769.8M | $756.5M |
| Operating expenses | $547.2M | $688.0M | $563.0M | $470.9M | $459.9M |
| Research and development | $94.8M | $99.5M | $96.7M | $92.5M | $87.1M |
| Selling, general and administrative | $452.4M | $588.5M | $466.4M | $378.4M | $372.8M |
| Operating income | $251.9M | $102.3M | $206.7M | $298.9M | $296.6M |
| Interest expense | – | – | – | $11.2M | $11.3M |
| Income tax | $58.8M | $25.1M | $17.6M | $53.2M | $38.3M |
| Net income | $181.9M | $73.4M | $168.1M | $285.3M | $272.1M |
| EPS, basic | $1.17 | $0.47 | $1.07 | $1.81 | $6.93 |
| EPS, diluted | $1.16 | $0.46 | $1.05 | $1.76 | $6.63 |
| Weighted shares, basic | 156.0M | 157.5M | 157.7M | 157.2M | 39.2M |
| Weighted shares, diluted | 157.0M | 159.7M | 160.8M | 161.9M | 41.0M |
| Margins and growth | |||||
| Gross margin | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% |
| Operating margin | 20.7% | 8.4% | 17.8% | 26.3% | 26.8% |
| Net margin | 15.0% | 6.0% | 14.5% | 25.1% | 24.6% |
| Revenue growth, year over year | −0.4% | +5.2% | +2.0% | +2.8% | +18.7% |
| Net income growth, year over year | +147.8% | −56.3% | −41.1% | +4.9% | +93.8% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Aug 12, 2026 | Aug 6, 2025 | Aug 7, 2024 | Aug 8, 2023 | Aug 4, 2022 |
| Cash and equivalents | $264.7M | $162.2M | $151.8M | $180.6M | $172.6M |
| Short-term investments | – | – | $1.07M | $23.7M | – |
| Accounts receivable | $216.6M | $206.9M | $241.4M | $218.5M | $194.5M |
| Inventory | $195.7M | $189.4M | $179.7M | $171.6M | $141.1M |
| Total current assets | $744.4M | $608.3M | $617.4M | $621.5M | $605.6M |
| Property, plant and equipment | $231.8M | $245.7M | $251.2M | $226.2M | $223.2M |
| Goodwill | $975.4M | $980.9M | $972.7M | $872.7M | $822.1M |
| Intangible assets | $303.5M | $365.6M | $507.1M | $534.6M | $531.5M |
| Total assets | $2.59B | $2.56B | $2.70B | $2.64B | $2.29B |
| Accounts payable | $26.7M | $25.3M | $38.0M | $25.7M | $33.9M |
| Short-term debt | – | – | – | – | $12.5M |
| Total current liabilities | $163.7M | $175.8M | $159.4M | $128.5M | $176.0M |
| Shareholders' equity | $2.11B | $1.92B | $2.07B | $1.97B | $1.70B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Aug 12, 2026 | Aug 6, 2025 | Aug 7, 2024 | Aug 8, 2023 | Aug 4, 2022 |
| Operating cash flow | $292.1M | $287.6M | $299.0M | $254.4M | $325.3M |
| Capital expenditures | $28.9M | $31.0M | $62.9M | $38.2M | $44.9M |
| Free cash flow | $263.2M | $256.6M | $236.1M | $216.1M | $280.4M |
| Depreciation and amortization | $97.4M | $109.9M | $111.7M | $107.2M | $101.1M |
| Stock-based compensation | $41.4M | $40.8M | $38.0M | $39.2M | $42.2M |
| Dividends paid | $49.9M | $50.4M | $50.4M | $50.3M | $50.2M |
| Share buybacks | $41.7M | $275.7M | $80.0M | $19.6M | $160.9M |
| Investing cash flow | -$18.2M | -$35.2M | -$203.0M | -$265.6M | -$96.9M |
| Financing cash flow | -$169.1M | -$253.9M | -$122.4M | $22.6M | -$242.9M |
| Net change in cash | $102.5M | $10.4M | -$28.8M | $8.00M | -$26.5M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 3.4% | 3.3% | 3.3% | 3.5% | 3.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2026 | 157.1M | +0.8% | SEC |
| Oct 9, 2026 | 157.1M | +0.8% | SEC |
| Aug 17, 2026 | 156.8M | +0.8% | SEC |
| Apr 29, 2026 | 156.6M | −0.1% | SEC |
| Jan 29, 2026 | 156.5M | −1.0% | SEC |
| Oct 30, 2025 | 155.8M | −1.9% | SEC |
| Aug 18, 2025 | 155.5M | −1.9% | SEC |
| May 1, 2025 | 156.8M | −0.5% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Jun 30, 2021, from 13F share counts: 4-for-1 in Q4 2022.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.